10x Genomics Inc.

NASDAQ: TXG · Real-Time Price · USD
13.36
0.12 (0.91%)
At close: Aug 15, 2025, 3:59 PM
13.34
-0.11%
After-hours: Aug 15, 2025, 05:13 PM EDT

10x Genomics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
34.54M -34.36M -49.03M -35.75M -37.9M -59.95M -48.95M -92.99M -62.41M -50.75M -17.21M -41.91M -64.46M -42.41M -18.45M -17.17M -11.05M -11.55M
Depreciation & Amortization
9.65M 9.81M 10.56M 10.75M 10.9M 11.49M 11.71M 11.42M 11.88M 8.62M 8.47M 8.12M 8.44M 7.97M 7.32M 7.28M 7.19M 6.47M
Stock-Based Compensation
27.56M 31.08M 32.54M 33.59M 38.49M 36.13M 38.92M 40.23M 45.7M 42.1M 40.97M 33.51M 36.31M 26.05M 26.9M 25.95M 26.93M 16.18M
Other Working Capital
-858K -12.56M 6.77M 5.23M -112K -24.46M 23.63M 33.89M -413K -31.01M 2.93M 10.25M 2.14M -20.46M 6.73M -18.22M -11.57M -11.29M
Other Non-Cash Items
-351K -461K 552K 64K 66K 2.9M -16.83M 26.5M 463K 1.86M 837K 660K 277K 183K 13K 64.55M 36K 30K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 23.85M -26.64M 2.79M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-53.69M 28.28M -1.38M 12.99M -4.07M -6.3M 17.07M 16.17M -9.93M -5.96M -19.34M -9.94M 2.46M -12.59M -9.99M -42.27M -19.98M -15.21M
Operating Cash Flow
17.71M 34.35M -6.75M 21.64M 7.5M -15.72M 25.76M -25.3M -11.53M -4.13M 13.72M -9.56M -16.96M -20.8M 5.8M -26.22M 3.12M -4.08M
Capital Expenditures
-1.58M -1.89M -2.72M -3.89M -3.88M -2.91M -3.45M -15.44M -25.36M -5.28M -39.73M -36.57M -27.22M -28.14M -27.62M -20.23M -14.57M -38.87M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.5M -1.5M 1.5M 1.5M n/a n/a n/a -5.45M
Purchase of Investments
-49.36M n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.5M -11.32M -29.22M -242.33M n/a n/a n/a n/a
Sales Maturities Of Investments
50M n/a n/a 271K 15.82M 13.54M 16.55M 20.34M 20.89M 125.24M 9.06M 16.77M 28.91M 12.91M n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -48.88M n/a n/a n/a n/a n/a 20.89M 124.52M 1.5M 5.44M -1.5M -1.5M n/a n/a n/a n/a
Investing Cash Flow
-939K -1.89M -51.59M -3.62M 11.95M 10.63M 13.1M 4.9M -4.46M 119.96M -33.17M -32.63M -27.53M -257.56M -27.62M -20.23M -14.57M -44.32M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.52M n/a n/a n/a n/a n/a n/a n/a 7.1M -5.81M 5M 2.04M 6.36M 2.42M 8.9M 6.68M 16.19M 3.52M
Financial Cash Flow
3.52M 422K 4.52M 156K 4.6M 1.64M 5.61M 4.37M 7.1M -3.41M 5M 2.04M 6.36M 2.42M 8.9M 6.68M 16.19M 3.52M
Net Cash Flow
20.65M 32.99M -54.09M 18.34M 24.04M -3.5M 44.55M -16.11M -8.94M 112.44M -14.2M -40.24M -38.32M -275.96M -12.99M -39.64M 4.75M -44.69M
Free Cash Flow
16.13M 32.46M -9.46M 17.75M 3.62M -18.64M 22.31M -40.74M -36.88M -9.41M -26.01M -46.14M -44.18M -48.94M -21.81M -46.44M -11.45M -42.95M